Thanks Carelbi,
I don't mind those figures at all.
I see your break-even scenario as a worst case for a number of reasons:
- I believe some of the other costs (such as admin, D&A) are built in to the COP already. That's why the COP drops when Phase 2 starts up in parallel.
- Phase 1 COP is top end of the estimates with a clear message that they can work this down as they fine tune the plant.
- 20% discount to basket may be correct initially but there'll be a premium for reliable top quality custom made product as EN said.
Of course the basket price could go lower but it appears noone will make a profit under that scenario even Baotou.
Your phase 2 scenario @ 22c per share is about where I expect us to be for the FY 14 (phase 2 half sold, better numbers otherwise) and that realistically translates to a SP over $2.
Your 90c scenario is certainly not far fetched and would make for excellent returns!
- Forums
- ASX - By Stock
- LYC
- realistic fair value
LYC
lynas rare earths limited
Add to My Watchlist
1.45%
!
$10.16

realistic fair value, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.16 |
Change
0.145(1.45%) |
Mkt cap ! $9.564B |
Open | High | Low | Value | Volume |
$10.18 | $10.34 | $10.13 | $28.75M | 2.810M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 9507 | $10.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.16 | 4110 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 5411 | 10.150 |
31 | 18985 | 10.140 |
23 | 15135 | 10.130 |
14 | 12819 | 10.120 |
9 | 27405 | 10.110 |
Price($) | Vol. | No. |
---|---|---|
10.160 | 4987 | 11 |
10.170 | 6141 | 14 |
10.180 | 7035 | 11 |
10.190 | 8864 | 12 |
10.200 | 8814 | 10 |
Last trade - 11.31am 16/07/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online